PARP-1 Inhibitors In Oncology
Structure Based Drug Design
Glycans in the Biotechnology and Pharmaceutical Industries Lecture 42 Carolyn R. Bertozzi UC Berkeley.
PhysChem Forum, 29 Nov 2006, Newhouse 1 Memories and the future: From experimental to in silico physical chemistry Han van de Waterbeemd AstraZeneca, DMPK.
INFSO-RI-508833 Enabling Grids for E-sciencE Using Grid Computing to Accelerate Structure-Based Design Against Influenza A Neuraminidases.
Chemical Data and Computer-Aided Drug Discovery Mike Gilson School of Pharmacy [email protected] 2-0622.